METTL3 and colorectal carcinoma: m6A modification and methyltransferase-like 3 (METTL3) expression are significantly elevated in CRC patient tissues, and METTL3 promotes the methylation modification of miR-181b 5p and its expression via DiGeorge syndrome critical region 8 (DGCR8).